**Moscow, Russia October 10, 2017** – **InSysBio LLC**, one of the pioneers in Quantitative Systems Pharmacology (QSP) modeling and simulation for the drug development, announced a renewal of the corporate identity.
>“Lately we have become more successful and have grown bigger. We are expanding our business and are attracting new customers and partners. And now we need to become more vivid and recognizable. That is why rebranding of the company is a logical step”, Oleg Demin Jr, the head of Business Development, spoke about the reasons for such changes.
>“The official name InSysBio is now short and memorable. A new symbol is a cell made of gear-wheels. It shows that we consider the living organism and its processes as parts of the mechanism that is accurately described in our models and platforms. Corporate colors are just the employees’ favorite colors. It's so important to surround yourself with what you like and do what you love”, Oleg explained the meanings of attributes of the corporate identity.
You can meet the new InSysBio in a week at the eighth American Conference on Pharmacometrics (ACoP8), to be held from October 15th to October 18th, 2017. The meeting will take place at the Marriott Resort: Harbor Beach Hotel, Fort Lauderdale, Florida.
See InSysBio ACoP8 [Agenda here](http://insilicobio.ru/share/ACoP8_agenda.pdf). Don’t miss our exhibition **booth #4**.
| ← | September 2024 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
| ||||||
|
2
|
3
|
4
1.
04 Sep 2024 16:07
Now B cells model reflects the current views on the processes
InSysBio launches Immune Response Template (IRT) version 3.6.3. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system
|
5
|
6
|
7
|
8
|
|
9
|
10
1.
10 Sep 2024 18:36
InSysBio team to publish the new article in PSPJournal
The new article "Quantitative systems pharmacology model of α-synuclein pathology in Parkinson's disease-like mouse for investigation of passive immunotherapy mechanisms" by Olga Ivanova and Tatiana Karelina was published in PSPJournal at the end of August 2024
|
11
1.
11 Sep 2024 15:25
InSysBio to take part in ACoP 2024
InSysBio announces its participation in the 15th American Conference on Pharmacometrics (ACoP). Oleg Demin Jr, Scientific Director, Oncology & Immuno-Oncology, will be a co-chair and speaker of the session "Advancing QSP: From Virtual Patient To Digital Twin". InSysBio team is going to present its modeling services & software to optimize drug development at the Booth #11 and 9 posters in frames of the Conference
|
12
|
13
|
14
|
15
|
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
|
30
| ||||||